Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/99957
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLu, K.en
dc.contributor.authorAsyifah, M. R.en
dc.contributor.authorShao, F.en
dc.contributor.authorZhang, D.en
dc.date.accessioned2014-06-11T04:56:25Zen
dc.date.accessioned2019-12-06T20:14:01Z-
dc.date.available2014-06-11T04:56:25Zen
dc.date.available2019-12-06T20:14:01Z-
dc.date.copyright2014en
dc.date.issued2014en
dc.identifier.citationLu, K., Asyifah, M., Shao, F., & Zhang, D. (2014). Development of HIV-1 Fusion Inhibitors Targeting gp41. Current Medicinal Chemistry, 21(17), 1976-1996.en
dc.identifier.issn0929-8673en
dc.identifier.urihttps://hdl.handle.net/10356/99957-
dc.description.abstractThe HIV-1 envelope protein glycoprotein 41 (gp41) is crucial in the HIV-1 infection process, therefore gp41 has emerged as an attractive target for drug design against AIDS. During the past few decades, tremendous efforts have been made on developing inhibitors that can prevent the HIV-1 entry process via suppressing functional gp41. In this review, the development of HIV-1 fusion inhibitors targeting gp41 including peptide inhibitors, small molecule inhibitors, vaccines and neutralized antibodies will be discussed.en
dc.language.isoenen
dc.relation.ispartofseriesCurrent medicinal chemistryen
dc.rights© 2014 Bentham Science Publishers.en
dc.subjectDRNTU::Science::Medicine::Biomedical engineeringen
dc.titleDevelopment of HIV-1 fusion inhibitors targeting gp41en
dc.typeJournal Articleen
dc.contributor.schoolSchool of Physical and Mathematical Sciencesen
dc.identifier.doi10.2174/0929867321666131218094559en
item.fulltextNo Fulltext-
item.grantfulltextnone-
Appears in Collections:SPMS Journal Articles

Google ScholarTM

Check

Altmetric


Plumx

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.